CSIMarket
 


Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 

Zimmer Biomet Holdings Inc 's Leverage Ratio

ZBH's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 6.45%, Leverage Ratio fell to 0.75, below the Zimmer Biomet Holdings Inc 's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the third quarter 2024, 16 other companies have achieved lower Leverage Ratio than Zimmer Biomet Holdings Inc in the III Quarter 2024. While Leverage Ratio total ranking has improved so far in the third quarter 2024 to 209, from total ranking in the second quarter 2024 at 1289 .

Explain Leverage Ratio?
Who are ZBH Customers?
What are ZBH´s Total Liabilities?


ZBH Leverage Ratio (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Equity Change -1.08 % 3 % 3.69 % 3.83 % 2.18 %
Y / Y Total Liabilities Change 7.34 % -1.61 % -2.62 % -0.32 % -4.2 %
Leverage Ratio MRQ 0.75 0.69 0.7 0.72 0.7
ZBH's Total Ranking # 209 # 1289 # 0 # 0 # 1303
Seq. Equity Change -2.87 % 1.14 % 0.94 % -0.24 % 1.13 %
Seq. Total Liabilities Change 6.45 % -0.85 % -1.8 % 3.56 % -2.43 %



Leverage Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 17
Healthcare Sector # 48
Overall Market # 209


Leverage Ratio Statistics
High Average Low
1.77 1.08 0.52
(Sep 30 2016)   (Dec 31 2013)




Financial Statements
Zimmer Biomet Holdings Inc 's Equity $ 12,383 Millions Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Total Liabilities $ 9,346 Millions Visit ZBH's Balance sheet
Source of ZBH's Sales Visit ZBH's Sales by Geography


Cumulative Zimmer Biomet Holdings Inc 's Leverage Ratio

ZBH's Leverage Ratio for the trailling 12 Months

ZBH Leverage Ratio

(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Equity TTM Growth -1.08 % 3 % 3.69 % 3.83 % 2.18 %
Y / Y Total Liabilities TTM Growth 7.34 % -1.61 % -2.62 % -0.32 % -4.2 %
Leverage Ratio TTM 0.72 0.7 0.71 0.72 0.73
Total Ranking TTM # 198 # 7 # 0 # 0 # 89
Seq. Equity TTM Growth -2.87 % 1.14 % 0.94 % -0.24 % 1.13 %
Seq. Total Liabilities TTM Growth 6.45 % -0.85 % -1.8 % 3.56 % -2.43 %


On the trailing twelve months basis Due to the net new borrowings of 6.45% during the trailing twelve months finishing in the III Quarter 2024, cumulativeLeverage Ratio improved to 0.72, below the Zimmer Biomet Holdings Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 15, during the past 12 months, other companies have achieved lower Leverage Ratio than Zimmer Biomet Holdings Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2024, compared to the prior period, from 7 to 198.

Explain Leverage Ratio?
Who are ZBH Customers?
What are ZBH´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 16
Healthcare Sector # 46
Within the Market # 198


trailing twelve months Leverage Ratio Statistics
High Average Low
1.7 1.02 0.7
(Jun 30 2017)   (Jun 30 2024)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2024, within Medical Equipment & Supplies Industry Leverage RatioSep 30 2024 MRQ Total LiabilitiesSep 30 2024 MRQ Equity
Lensar Inc   1.73 $ 39.281  Millions$ 22.738  Millions
Sonoma Pharmaceuticals Inc   1.56 $ 8.333  Millions$ 5.352  Millions
Integra Lifesciences Holdings Corp  1.47 $ 2,234.663  Millions$ 1,521.587  Millions
Henry Schein Inc   1.45 $ 6,004.000  Millions$ 4,139.000  Millions
Conmed Corporation  1.41 $ 1,317.028  Millions$ 932.896  Millions
Masimo Corp  1.11 $ 1,624.600  Millions$ 1,463.200  Millions
Carlisle Companies Incorporated  1.06 $ 2,927.900  Millions$ 2,762.900  Millions
Cadre Holdings inc   1.05 $ 316.334  Millions$ 300.281  Millions
Msa Safety Inc  1.05 $ 1,146.582  Millions$ 1,095.345  Millions
Bausch and Lomb Corp  1.04 $ 6,926.000  Millions$ 6,661.000  Millions
Genedx Holdings Corp   1.00 $ 204.339  Millions$ 204.501  Millions
Innovage Holding Corp   0.96 $ 258.666  Millions$ 269.053  Millions
Cvrx inc   0.96 $ 62.490  Millions$ 65.183  Millions
Integer Holdings Corporation  0.95 $ 1,537.580  Millions$ 1,621.186  Millions
Zimvie Inc   0.93 $ 376.310  Millions$ 406.638  Millions
Livanova Plc  0.93 $ 1,211.914  Millions$ 1,310.044  Millions
Treace Medical Concepts Inc   0.87 $ 91.531  Millions$ 104.906  Millions
National Vision Holdings Inc   0.81 $ 678.971  Millions$ 839.997  Millions
Privia Health Group Inc   0.79 $ 524.502  Millions$ 662.182  Millions
Merit Medical Systems Inc  0.79 $ 1,043.209  Millions$ 1,323.406  Millions
Pulmonx Corporation  0.78 $ 73.476  Millions$ 93.925  Millions
Myomo Inc   0.76 $ 7.021  Millions$ 9.292  Millions
Zimmer Biomet Holdings Inc   0.75 $ 9,345.600  Millions$ 12,383.200  Millions
Medinotec Inc   0.74 $ 1.869  Millions$ 2.530  Millions
Boston Scientific Corporation  0.73 $ 15,391.000  Millions$ 20,956.000  Millions
Pro dex Inc   0.72 $ 22.368  Millions$ 30.877  Millions
Axogen inc   0.71 $ 70.988  Millions$ 99.407  Millions
Envista Holdings Corporation  0.71 $ 2,171.100  Millions$ 3,072.500  Millions
Enovis Corp  0.65 $ 2,172.305  Millions$ 3,333.299  Millions
Align Technology inc   0.61 $ 2,421.620  Millions$ 3,944.354  Millions

Date modified: 2024-10-31T09:16:26+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com